afamelanotide
afamelanotide is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including SCENESSE. Available dosage form: implant.
Drug Details
- Generic Name
- afamelanotide
- Brand Names
- SCENESSE
- Application Number
- NDA210797
- Sponsor
- CLINUVEL INC.
- NDC Codes
- 2
- Dosage Forms
- IMPLANT
- Routes
- SUBCUTANEOUS
- Active Ingredients
- AFAMELANOTIDE
Indications and Usage
SCENESSE ® is indicated to increase pain free light exposure in adult patients with a history of phototoxic reactions from erythropoietic protoporphyria (EPP). SCENESSE is a melanocortin 1 receptor (MC1-R) agonist indicated to increase pain free light exposure in adult patients with a history of phototoxic reactions from erythropoietic protoporphyria (EPP)